Systematic Reviews
Copyright ©The Author(s) 2022.
World J Clin Cases. Dec 16, 2022; 10(35): 12946-12958
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.12946
Figure 1
Figure 1 Potential pathway of denovo non-alcoholic fatty liver disease in animal models with boxes in green representing potential treatment options. NAFLD: Non-alcoholic fatty liver disease.
Figure 2
Figure 2 Factors involved in development of denovo non-alcoholic fatty liver disease after pancreatectomy. NAFLD: Non-alcoholic fatty liver disease; VLDL: Very low-density lipoprotein; TP: Total pancreatectomy; DP: Distal pancreatectomy; PD: Pancreatoduodenectomy.
Figure 3
Figure 3 Hepatic steatosis on non-contrast computed tomography scan measured by regions of interest drawn to calculate average Hounsfield units and liver to spleen ratio.